Michelle Logan Thermo Fisher Scientific
Michelle Logan joined Thermo Fisher Scientific with the acquisition of Patheon in 2017 and currently is Vice President and General Manager for Drug Product Division North America Business Unit. With over 20 years in the pharmaceutical industry, she has held multiple roles within the organization leading Sterile Injectable, Oral Solid Dose, and Quality business units. In addition to her experience at Thermo Fisher Scientific, Michelle led the Quality organization for a medical device company, Coeur, Inc., and was part of the External Manufacturing Quality organization for GlaxoSmithKline.
Michelle graduated from the University of North Carolina at Chapel Hill where she earned a Bachelor of Science degree in Biology. She resides in Greenville with her husband Gerald. They have four sons Jeramy, Alec, Korbin, and Carson.
Michelle graduated from the University of North Carolina at Chapel Hill where she earned a Bachelor of Science degree in Biology. She resides in Greenville with her husband Gerald. They have four sons Jeramy, Alec, Korbin, and Carson.